How did GUTS' R&D costs trend in 2023?
5/9/2025 03:25pm
Fractyl Health (GUTS) significantly increased its R&D spending in 2023, with a cumulative expenditure of $38.04 million reported for the year ending December 31, 2023. This represents a substantial investment in research and development, indicating the company's commitment to innovation and potential growth.
|code|Ticker|Name|Date|R&D Expenses|R&D Expenses YoY|market_code|
|---|---|---|---|---|---|---|
|GUTS|GUTS.O|Fractyl Health|2023 Q1|9349000||185|
|GUTS|GUTS.O|Fractyl Health|2023 Q2|9141000||185|
|GUTS|GUTS.O|Fractyl Health|2023 Q3|9382000|9.923842999414177|185|
|GUTS|GUTS.O|Fractyl Health|2023 Q4|1.0166E7|17.976093768132763|185|